Anthony F. Lever

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Anthony F. Lever, David Hole, C. Gillis et al. · The Lancet · 1998 · 545 citations

Inhibitory Activity, Oncology, Medicine +8

Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.

S A Griffin, W. Carson Brown, Fiona MacPherson et al. · Hypertension · 1991 · 395 citations

Hypertension, Vascular Hypertrophy, Angiotensin Ii +12

Abnormalities of glucocorticoid metabolism and the renin???angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure

Graham Watt, Stephen Harrap, Christopher Foy et al. · Journal of Hypertension · 1992 · 304 citations

Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial

J. A. Millar, Anthony F. Lever, Valerie Burke · Journal of Hypertension · 1999 · 282 citations

Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men

Chris Isles, David Hole, V M Hawthorne et al. · The Lancet · 1992 · 277 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Health Policy +11